Indication
Adult Health Subjects
1 clinical trial
2 products
Clinical trial
A Randomized, Double-Blind, Placebo- and Active-Controlled, 3-Way Crossover Study in Healthy Subjects to Determine the Effect of Omaveloxolone on QTc IntervalStatus: Completed, Estimated PCD: 2023-09-01
Product
MoxifloxacinProduct
Omaveloxolone